MA37966B1 - Utilisation de venins d'araignées pour le blanchiment/la dépigmentation de la peau et composition comprenant des molécules de venins d'araignées ou des analogues synthétiques - Google Patents

Utilisation de venins d'araignées pour le blanchiment/la dépigmentation de la peau et composition comprenant des molécules de venins d'araignées ou des analogues synthétiques

Info

Publication number
MA37966B1
MA37966B1 MA37966A MA37966A MA37966B1 MA 37966 B1 MA37966 B1 MA 37966B1 MA 37966 A MA37966 A MA 37966A MA 37966 A MA37966 A MA 37966A MA 37966 B1 MA37966 B1 MA 37966B1
Authority
MA
Morocco
Prior art keywords
spider
bleaching
skin
depigmentation
composition
Prior art date
Application number
MA37966A
Other languages
English (en)
Inventor
Kamel Mabrouk
José Luis
Pomyers Harold De
Denis Bertin
Abd Haq Bengeloune
Marion Verdoni
Didier Gigmes
Hermine Roudaut
Original Assignee
Laboratoire Inoya
Latoxan
Univ Aix Marseille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Inoya, Latoxan, Univ Aix Marseille filed Critical Laboratoire Inoya
Publication of MA37966B1 publication Critical patent/MA37966B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne l'utilisation de molécules de venin d'araignée ou de leurs analogues synthétiques pour le blanchiment de la peau. La présente invention concerne également des compositions comprenant des molécules de venin d'araignée ou leurs analogues synthétiques pour le blanchiment/la dépigmentation de la peau. L'invention concerne enfin un procédé non thérapeutique pour le blanchiment de la peau humaine, comprenant l'application topique d'une quantité efficace de la composition de l'invention sur ladite peau humaine.
MA37966A 2012-09-05 2013-09-05 Utilisation de venins d'araignées pour le blanchiment/la dépigmentation de la peau et composition comprenant des molécules de venins d'araignées ou des analogues synthétiques MA37966B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12006270.8A EP2705830A1 (fr) 2012-09-05 2012-09-05 Utilisation de venins d'araignée pour le blanchiment de la peau/dépigmentation et composition comprenant des dérivés de venins d'araignée
PCT/EP2013/002666 WO2014037111A2 (fr) 2012-09-05 2013-09-05 Utilisation de venins d'araignées pour le blanchiment/la dépigmentation de la peau et composition comprenant des molécules de venins d'araignées ou des analogues synthétiques

Publications (1)

Publication Number Publication Date
MA37966B1 true MA37966B1 (fr) 2018-04-30

Family

ID=46832191

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37966A MA37966B1 (fr) 2012-09-05 2013-09-05 Utilisation de venins d'araignées pour le blanchiment/la dépigmentation de la peau et composition comprenant des molécules de venins d'araignées ou des analogues synthétiques

Country Status (10)

Country Link
US (1) US10064814B2 (fr)
EP (2) EP2705830A1 (fr)
AP (1) AP2015008298A0 (fr)
BR (1) BR112015004741A2 (fr)
CA (1) CA2906241A1 (fr)
FR (1) FR2994847B1 (fr)
MA (1) MA37966B1 (fr)
TN (1) TN2015000077A1 (fr)
WO (1) WO2014037111A2 (fr)
ZA (1) ZA201501446B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101613302B1 (ko) * 2015-12-30 2016-04-18 (주)넥스젠바이오텍 Sv82 폴리펩타이드 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208523A3 (fr) * 1985-07-08 1989-04-26 Peter Norman Russell Usherwood Antagonistes du glutamate
ATE267009T1 (de) * 1993-02-23 2004-06-15 Brigham & Womens Hospital Calciumrezeptoraktive moleküle
FR2704428B1 (fr) * 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
EP1427404A4 (fr) * 2001-08-20 2005-10-26 Maiken Nedergaard Traitement de tumeurs gliales avec des antagonistes du glutamate
US7689957B2 (en) 2007-09-10 2010-03-30 Synopsys, Inc. Identifying and improving robust designs using statistical timing analysis
KR101225114B1 (ko) * 2010-01-11 2013-01-22 동성제약주식회사 봉독을 유효성분으로 함유하는 피부 미백 및 피부질환 예방 및 치료용 조성물
WO2011103577A1 (fr) * 2010-02-22 2011-08-25 Schloss John V Produits alimentaires améliorés, préparation, et procédés thérapeutiques

Also Published As

Publication number Publication date
FR2994847A1 (fr) 2014-03-07
EP2892500B1 (fr) 2019-05-08
US10064814B2 (en) 2018-09-04
ZA201501446B (en) 2015-12-23
EP2705830A1 (fr) 2014-03-12
WO2014037111A3 (fr) 2014-12-18
US20150231061A1 (en) 2015-08-20
EP2892500A2 (fr) 2015-07-15
WO2014037111A9 (fr) 2015-07-02
AP2015008298A0 (en) 2015-03-31
BR112015004741A2 (pt) 2017-07-04
FR2994847B1 (fr) 2021-04-30
WO2014037111A2 (fr) 2014-03-13
TN2015000077A1 (en) 2016-06-29
CA2906241A1 (fr) 2014-03-13

Similar Documents

Publication Publication Date Title
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
IN2014DN09931A (fr)
UA113543C2 (xx) Сполуки та композиції для модулювання egfr активності
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
IN2014DN09928A (fr)
IN2014DN09937A (fr)
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
EA201791007A2 (ru) Соединения и их применения для модуляции гемоглобина
EA201591426A1 (ru) Соединения и их применения для модуляции гемоглобина
EA201100632A1 (ru) Применение дитиинтетракарбоксимидов для борьбы с фитопатогенными грибами
EA201490922A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
EA201170349A1 (ru) Модуляторы mif
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
MA47356B1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
MX2013003309A (es) Compuestos de benzamida sustituidos.
BR112014028991A2 (pt) triazóis como inibidores de kv3
TN2011000669A1 (fr) L-serine pour son utilisation en tant que medicament pour prevenir et/ou traiter une reaction inflammatoire de la peau
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
FR2991578B1 (fr) Composes pour application anti-age et peau seche
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
FR2961402B1 (fr) Compositions contenant des arabinoxylo-oligosaccharides et leurs utilisations
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
EA201071369A1 (ru) Композиции для лечения выпадения волос